Genetic Analysis in Human Disease. Learning Objectives Describe the differences between a linkage analysis and an association analysis Identify potentially.

Slides:



Advertisements
Similar presentations
Linkage and Genetic Mapping
Advertisements

Lecture 41 Prof Duncan Shaw. Genetic Variation Already know that genes have different alleles - how do these arise? Process of mutation - an alteration/change.
What is an association study? Define linkage disequilibrium
Genetic research designs in the real world Vishwajit L Nimgaonkar MD, PhD University of Pittsburgh
Meta-analysis for GWAS BST775 Fall DEMO Replication Criteria for a successful GWAS P
Genetic Analysis in Human Disease
Perspectives from Human Studies and Low Density Chip Jeffrey R. O’Connell University of Maryland School of Medicine October 28, 2008.
Mapping Genes for SLE: A Paradigm for Human Disease? Stephen S. Rich, Ph.D. Department of Public Health Sciences Wake Forest University School of Medicine.
Virginia Rodriguez Funes, MD, FACS El Salvador. Background  The Latin American population it is now the largest single ethnic group in the United States,
Published Genome-Wide Associations through ,617 published GWA at p≤5X10 -8 for 249 traits Autism marker Multiple Sclerosis Marker The GWAS Human.
Ferdinand van ’t Hooft Cardiovascular Genetics and Genomics Group Karolinska Institutet, Stockholm, Sweden Genome-Wide Association Study GWAS
THE RELATIONSHIP BETWEEN GENOTYPE AND PHENOTYPE – WHAT WE KNOW AND WHAT WE DON’T KNOW. PAUL SCHLIEKELMAN DEPARTMENT OF STATISTICS UNIVERSITY OF GEORGIA.
Office hours Wednesday 3-4pm 304A Stanley Hall. Fig Association mapping (qualitative)
MSc GBE Course: Genes: from sequence to function Genome-wide Association Studies Sven Bergmann Department of Medical Genetics University of Lausanne Rue.
Positional Cloning LOD Sib pairs Chromosome Region Association Study Genetics Genomics Physical Mapping/ Sequencing Candidate Gene Selection/ Polymorphism.
Something related to genetics? Dr. Lars Eijssen. Bioinformatics to understand studies in genomics – São Paulo – June Image:
Genome-Wide Association Studies Xiaole Shirley Liu Stat 115/215.
Office hours Wednesday 3-4pm 304A Stanley Hall Review session 5pm Thursday, Dec. 11 GPB100.
Genomewide Association Studies.  1. History –Linkage vs. Association –Power/Sample Size  2. Human Genetic Variation: SNPs  3. Direct vs. Indirect Association.
Give me your DNA and I tell you where you come from - and maybe more! Lausanne, Genopode 21 April 2010 Sven Bergmann University of Lausanne & Swiss Institute.
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
Manolis Kellis Broad Institute of MIT and Harvard
Genome Variations & GWAS
Exploring the behavioral genetics of Trade and Cooperation Arcadi Navarro and Elodie Gazave July 5th 2007.
Rare and common variants: twenty arguments G.Gibson Homework 3 Mylène Champs Marine Flechet Mathieu Stifkens 1 Bioinformatics - GBIO K.Van Steen.
Standardization of Pedigree Collection. Genetics of Alzheimer’s Disease Alzheimer’s Disease Gene 1 Gene 2 Environmental Factor 1 Environmental Factor.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Comments on Rare Variants Analyses Ryo Yamada Kyoto University 2012/08/27 Japan.
Introduction to BST775: Statistical Methods for Genetic Analysis I Course master: Degui Zhi, Ph.D. Assistant professor Section on Statistical Genetics.
The medical relevance of genome variability Gabor T. Marth, D.Sc. Department of Biology, Boston College
Analyzing DNA Differences PHAR 308 March 2009 Dr. Tim Bloom.
Multifactorial Traits
Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology
The Center for Medical Genomics facilitates cutting-edge research with state-of-the-art genomic technologies for studying gene expression and genetics,
The medical relevance of genome variability Gabor T. Marth, D.Sc. Department of Biology, Boston College Medical Genomics Course – Debrecen,
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
CS177 Lecture 10 SNPs and Human Genetic Variation
A basic review of genetics Dr. Danny Chan Associate Professor Assistant Dean (Faculty of Medicine) Department of Biochemistry Department of Biochemistry.
GWAS Hits and Functional Implications Peter Castaldi February 1, 2013.
From Genome-Wide Association Studies to Medicine Florian Schmitzberger - CS 374 – 4/28/2009 Stanford University Biomedical Informatics
Genome-Wide Association Study (GWAS)
Whole genome association studies Introduction and practical Boulder, March 2009.
Jianfeng Xu, M.D., Dr.PH Professor of Public Health and Cancer Biology Director, Program for Genetic and Molecular Epidemiology of Cancer Associate Director,
Lecture 6. Functional Genomics: DNA microarrays and re-sequencing individual genomes by hybridization.
MEME homework: probability of finding GAGTCA at a given position in the yeast genome, based on a background model of A = 0.3, T = 0.3, G = 0.2, C = 0.2.
Future Directions Pak Sham, HKU Boulder Genetics of Complex Traits Quantitative GeneticsGene Mapping Functional Genomics.
What’s the Difference? Genetic and Common Diseases.
An quick overview of human genetic linkage analysis
The International Consortium. The International HapMap Project.
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
An quick overview of human genetic linkage analysis Terry Speed Genetics & Bioinformatics, WEHI Statistics, UCB NWO/IOP Genomics Winterschool Mathematics.
The Future of Genetics Research Lesson 7. Human Genome Project 13 year project to sequence human genome and other species (fruit fly, mice yeast, nematodes,
Familial coronary artery disease Paul Brennan Clinical Director Northern Genetics Service Newcastle Hospitals NHS Foundation Trust North East and North.
An atlas of genetic influences on human blood metabolites Nature Genetics 2014 Jun;46(6)
Introduction to Genome Wide Association Studies Saharon Rosset Tel Aviv University.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Genome-Wides Association Studies (GWAS) Veryan Codd.
Genetic Analysis in Human Disease Kim R. Simpfendorfer, PhD Robert S.Boas Center for Genomics & Human Genetics The Feinstein Institute for Medical Research.
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
Brendan Burke and Kyle Steffen. Important New Tool in Genomic Medicine GWAS is used to estimate disease risk and test SNPs( the most common type of genetic.
Single Nucleotide Polymorphisms (SNPs
SNPs and complex traits: where is the hidden heritability?
Genomic Analysis: GWAS
Genome-wide Associations
Beyond GWAS Erik Fransen.
Type 2 Diabetes With type 2 diabetes, your body either resists the effects of insulin — a hormone that regulates the movement of sugar into your cells.
Medical genomics BI420 Department of Biology, Boston College
One SNP at a Time: Moving beyond GWAS in Psoriasis
Medical genomics BI420 Department of Biology, Boston College
Discovery From Data Repositories H Craig Mak  Nature Biotechnology 29, 46–47 (2011) 2013 /06 /10.
Presentation transcript:

Genetic Analysis in Human Disease

Learning Objectives Describe the differences between a linkage analysis and an association analysis Identify potentially confounding factors in a genetic study Define missing heritability

Question: 1) You have a grant to do a genetics study of the disease of your choice. What are 3 aspects you need to consider when recruiting subjects?  A) Phenotype, gender and age  B) Phenotype, gender and income  C) Gender, age and income  D) Age, income and education

Question: 2) You’ve analyzed 1,000 cases and 1,000 controls for an association study but found nothing significant. What went wrong?  A) Recruited too many subjects  B) Population was too homogeneous  C) Not enough subjects  D) Genotyped using only one platform

Question: 3) You’ve made it to the big time. From your GWAS analysis you have significant hits in known genes. What’s the next step?  A) End of story, move on to the next study  B) Develop new drugs  C) Replication/validation  D) Patent the SNPs

Power of Genetic Analysis Success stories  Age-related Macular Degeneration  Crohn’s Disease  Allopecia Areata  Type1 Diabetes Not so successful  Ovarian Cancer  Obesity

The spectrum of genetic effects in complex diseases

Getting Started Question to be answered Which gene(s) are responsible for genetic susceptibility for Disease A? What is the measurable difference  Clinical phenotype biomarkers, drug response, outcome Who is affected  Demographics male/female, ethnic/racial background, age

Study Design Linkage (single gene diseases: cystic fibrosis, Huntington’s disease, Duchene's Muscular Dystrophy)  Families Association (complex diseases: RA, SLE, breast cancer, autism, allopecia, AMD, Alzheimer’s)  Case - control

Linkage vs. Association Analysis 5M

Linkage Studies- all in the family Family based method to map location of disease causing loci Families  Multiplex  Trios  Sib pairs

Staged Genetic Analysis - RA Linkage/Association/Candidate Gene

Association Studies – numbers game Genome-Wide Association Studies (GWAS)  Tests the whole genome for a statistical association between a marker and a trait in unrelated cases and controls Affecteds Controls

Staged Genetic Analysis - RA Linkage/Association/Candidate Gene

So you have a hit: p< 5 x10 Validation/ replication Dense mapping/Sequencing Functional Analysis -7

Validation Independent replication set  Same inclusion/exclusion subject criteria  Sample size Genotyping platform  Same polymorphism Analysis Different ethnic group (added bonus)

Staged Genetic Analysis - RA Linkage/Association/Candidate Gene

Dense Mapping/Sequencing Identifies the boundaries of your signal  close in on the target gene/ causal variant  find other (common or rare) variants

Functional Analysis Does your gene make sense?  pathway  function  cell type  expression  animal models PTPN22: first non-MHC gene associated with RA (TCR signaling)

Perfect vs Imperfect Worlds Perfect world Linkage and/or GWAS – identify causative gene polymorphism for your disease Publish Imperfect world  nothing significant  identify genes that have no apparent influence in your disease of interest Now what?

What Happened? Disease has no genetic component.  Viral, bacterial, environmental Genetic effect is small and your sample size wasn’t big enough to detect it.  CDCV vs CDRV Phenotype /or demographics too heterogeneous  Too many outliers Wrong controls.  Population stratification; admixture Not asking the right question.  wrong statistics, wrong model

Meta-Analysis – Bigger is better Meta-analysis - combines genetic data from multiple studies; allows identification of new loci  Rheumatoid Arthritis  Lupus  Crohn’s disease  Alzheimer’s  Schizophrenia  Autism

Influence of Admixture Not all Subjects are the same

Missing heritability Except for a few diseases (AMD, T1D) genetics explains less than 50% of risk.  Large number of genes with small effects Other influences?

Other Contributors Any change in gene expression can influence disease state- not always related directly to DNA sequence Environmental Epigenetic MicroRNA Microbiome Copy Number Variation Gene-Gene Interactions Alternative splice sites/transcription start sites

Genome-Wide Association Studies The promise  Better understanding of biological processes leading to disease pathogenesis  Development of new treatments  Identify non-genetic influences of disease  Better predictive models of risk

GWAS – what have we found? 3800 SNPs identified for 427 diseases and traits Only 7% in coding regions >50% in DNAse sensitive sites, presumed regulatory regions

Genome-Wide Association Studies The reality  Few causal variants have been identified Clinical heterogeneity and complexity of disease  Genetic results don’t account for all of disease risk

Genome-Wide Association Studies The potential clinical applications  Risk prediction Type 1 Diabetes (MHC and 50 loci)  Disease subtyping/classification MODY: HNF1A- C- reactive protein biomarker  Drug development Ribavirin- induced anemia: ITPA variants protective  Drug toxicity/ adverse effects MCR4 SNPs and extreme SGA-induced weight gain (Manolio 2013)

Question: 1) You have a grant to do a genetics study of the disease of your choice. What are 3 aspects you need to consider when recruiting subjects?  A) Phenotype, gender and age  B) Phenotype, gender and income  C) Gender, age and income  D) Age, income and education

Answer: 1) You have a grant to do a genetics study of the disease of your choice. What are 3 aspects you need to consider when recruiting subjects?  A) Phenotype, gender and age

Question: 2) You’ve analyzed 1,000 cases and 1,000 controls for an association study but found nothing significant. What went wrong?  A) Recruited too many subjects  B) Population was too homogeneous  C) Not enough subjects  D) Genotyped using only one platform

Answer: 2) You’ve analyzed 1,000 cases and 1,000 controls for an association study but found nothing significant. What went wrong?  C) Not enough subjects

Question: 3) You’ve made it to the big time. From your GWAS analysis you have significant hits in known genes. What’s the next step?  A) End of story, move on to the next study  B) Develop new drugs  C) Replication/validation  D) Patent the SNPs

Answer: 3) You’ve made it to the big time. From your GWAS analysis you have significant hits in known genes. What’s the next step?  C) Replication/validation